'Acquired pneumonia' diaporamas de présentation

Community- Acquired Pneumonia (CAP); The Disease and its Management

Community- Acquired Pneumonia (CAP); The Disease and its Management. Toronto, November 9, 2013 Lionel A. Mandell MD. FRCPC. FRCP(LOND) Professor Emeritus of Medicine McMaster University Hamilton, Canada. Pneumonia. CAP. HCAP. HAP/VAP. Impact of the Disease. 5.6 million cases annually

1.02k views • 40 slides

CLINICAL EFFICACY Oral Telithromycin

CLINICAL EFFICACY Oral Telithromycin. George Rochester, PhD, CCRN Statistical Reviewer Division of Biometrics III Division of Anti-infective Drug Products rochesterg@cder.fda.gov. Outline. Phase III clinical database Censored data Clinical or bacteriologic efficacy by indication

330 views • 17 slides

Swallowing Muscle Dysfunction and Residual Factor of Dysphagia with Community- Acquired Pneumonia in the Elderly

The incidence of pneumonia in the United States increases with age, and pneumonia is the third leading cause of death in Japan. The rates of treatment for pneumonia and the incidence of the disease both increase steeply with age. Therefore, with the aging of the population, the increase in the number of patients hospitalized for pneumonia is expected to continue.

43 views • 4 slides

ABSTRACT

142 views • 1 slides